Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.03.18	Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc. (PR Newswire)
16.03.18	Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc. (PR Newswire)
16.03.18	Johnson & Johnson annonce une offre ferme de Platinum Equity pour acquérir LifeScan, Inc. (PR Newswire)
13.03.18	Lifshitz & Miller LLP Announces Investigation of 8point3 Energy Partners LP, Grandpoint Capital, Inc., Hardinge Inc., Johnson & Johnson, LJM Funds Management Ltd., Nationstar Mortgage Holdings Inc. (PR Newswire)
08.03.18	Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials (PR Newswire)
06.03.18	Johnson & Johnson to Participate in Barclays Global Healthcare Conference (PR Newswire)
05.03.18	New Drugs Approved In February (RTTNews)
23.02.18	Milliman: Public pension funding improves by $60 billion, funded ratio climbs to 73.1% in 2017 Q4 (PR Newswire)
20.02.18	Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference (PR Newswire)
20.02.18	J&J Reportedly Explores Sale Of $2 Bln Sterilization Division (RTTNews)
16.02.18	Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting (PR Newswire)
09.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018 (PR Newswire)
09.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018 (PR Newswire)
09.02.18	FDA Nod For JNJ, CORI Awaits Results In Q2, MDGL's HeFH Data Fails To Impress (RTTNews)
08.02.18	Johnson & Johnson to Participate in the 2018 CAGNY Conference (PR Newswire)
08.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Johnson & Johnson (JNJ) (PR Newswire)
08.02.18	Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio (PR Newswire)
07.02.18	Johnson & Johnson to Participate in RBC Capital Markets 2018 Global Healthcare Conference (PR Newswire)
01.02.18	MeiraGTx Receives Rare Pediatric Disease Designation for A002 for the Treatment of Achromatopsia Due to Mutations in the CNGB3 Gene (PR Newswire)
31.01.18	Johnson & Johnson to Participate in the Leerink Partners 7th Annual Global Healthcare Conference (PR Newswire)
25.01.18	Bayer Shares the Risk with Cotton Farmers (PR Newswire)
23.01.18	Forty of the Nation's Most Promising Young Scientists Named Finalists in Regeneron Science Talent Search 2018 (PR Newswire)
23.01.18	Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View (RTTNews)
23.01.18	Johnson & Johnson Q4 Earnings Rise 10% (RTTNews)
23.01.18	Johnson & Johnson Reports 2017 Fourth-Quarter Results: (PR Newswire)
23.01.18	Earnings In Focus: Jan. 23 (FUL, ATI, JNJ, PG, VZ) (RTTNews)
09.01.18	Small Business Funding Solutions: What to Do Differently in 2018 (PR Newswire)
07.01.18	New Drugs Approved In December (RTTNews)
03.01.18	Dr. Paul Janssen Award for Biomedical Research Issues 2018 Call for Nominations to Celebrate Champions of Science (PR Newswire)
02.01.18	Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018 (PR Newswire)
19.12.17	Johnson & Johnson to Participate in 36th Annual JP Morgan Health Care Conference (PR Newswire)
19.12.17	Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results (PR Newswire)
30.11.17	Johnson & Johnson to Participate in the BMO Capital Markets Healthcare Conference (PR Newswire)
20.11.17	Johnson & Johnson to Participate in the Citi 2017 Global Healthcare Conference (PR Newswire)
14.11.17	Johnson & Johnson Innovation lance le Digital Beauty QuickFire Challenge en vue de résoudre quelques-uns des plus grands problèmes des soins de la peau du grand public (PR Newswire)
14.11.17	Soins de la peau : Johnson & Johnson Innovation lance le défi « Digital Beauty QuickFire Challenge » pour s'attaquer à certains des problèmes de les plus coriaces (PR Newswire)
14.11.17	Johnson & Johnson Innovation lanciert die Digital Beauty QuickFire Challenge, um einige der schwierigsten Hautprobleme von Verbrauchern zu meistern (PR Newswire)
13.11.17	Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems (PR Newswire)
13.11.17	Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems (PR Newswire)
13.11.17	Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems (PR Newswire)
13.11.17	Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems (PR Newswire)
25.10.17	Judge Overturns Verdict In J&J Baby Powder Verdict (RTTNews)
25.10.17	Johnson & Johnson to Participate in the 26th Annual Credit Suisse Health Care Conference (PR Newswire)
22.10.17	California Court Overturns $417 Mln Verdict Linking J&J Baby Powder With Cancer (RTTNews)
19.10.17	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2017 (PR Newswire)
18.10.17	Johnson & Johnson Wins Reversal Of First St. Louis Talc-Cancer Verdict (RTTNews)
17.10.17	Johnson & Johnson Lifts FY17 Forecast As Q3 Results Top Estimates (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09:30		Novartis-Aktie: Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) gibt Hold-Bewertung bekannt
09:28		Gewinne in Zürich: SLI zum Start in Grün
09:28		Freundlicher Handel: SMI bewegt sich zum Handelsstart im Plus
09:28		Börse London: FTSE 100 zum Handelsstart fester
09:28		Zuversicht in Zürich: SPI verbucht zum Handelsstart Zuschläge
09:28		Pluszeichen in Europa: STOXX 50 verbucht zum Start Zuschläge
09:17		Novartis-Aktie fällt: Novartis will bei Krebskongressen zahlreiche Studiendaten präsentieren
09:17		Roche-Aktie dennoch schwächer: FDA gibt Roche grünes Licht für Gallenkrebs-Test

09:30

Novartis-Aktie: Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) gibt Hold-Bewertung bekannt

09:28

Gewinne in Zürich: SLI zum Start in Grün

09:28

Freundlicher Handel: SMI bewegt sich zum Handelsstart im Plus

09:28

Börse London: FTSE 100 zum Handelsstart fester

09:28

Zuversicht in Zürich: SPI verbucht zum Handelsstart Zuschläge

09:28

Pluszeichen in Europa: STOXX 50 verbucht zum Start Zuschläge

09:17

Novartis-Aktie fällt: Novartis will bei Krebskongressen zahlreiche Studiendaten präsentieren

09:17

Roche-Aktie dennoch schwächer: FDA gibt Roche grünes Licht für Gallenkrebs-Test

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.55	2.53 %	K V
Lonza Grp	529.40	1.53 %	K V
Part Grp Hldg	1’277.00	1.07 %	K V
UBS Group	28.49	0.67 %	K V
Nestle	76.46	0.61 %	K V
Sonova Hldg	311.20	-0.29 %	K V
Zurich Insur Gr	551.00	-0.36 %	K V
Swisscom	507.00	-0.49 %	K V
Swiss Life Hldg	729.20	-0.60 %	K V
Novartis	92.72	-1.02 %	K V

Nachrichten zu Johnson & Johnson

Aktien Top/Flop

Johnson & Johnson Peer Group Nachrichten

Meistgelesene Nachrichten